Resp - Cystic fibrosis treatment Flashcards
What is CF?
genetic disorder affecting the lungs, pancreas, liver, intestine, and reproductive organs
What are the signs of CF?
pulmonary disease, with recurrent infections and the production of copious viscous sputum, and malabsorption due to pancreatic insufficiency
Complications include hepatobiliary disease, osteoporosis, cystic fibrosis-related diabetes, and distal intestinal obstruction syndrome
Aims of treatment
Preventing and managing lung infections
Loosening and removing thick, sticky mucus from the lungs
Preventing or treating intestinal obstruction
Providing sufficient nutrition and hydration
What function is a key predictor?
lung function - optimising lung function is a major aim of care
What are the Non-Drug Treatment?
Provide advice on airway clearance, nebuliser use, musculoskeletal disorders, physical activity, and urinary incontinence (by specialist physiotherapists).
Regular exercise improves both lung function and overall fitness
What are the Drug Treatment?
Treatment is based on the prevention of lung infection and the maintenance of lung function.
Patients, who have clinical evidence of lung disease, the frequency of routine review should be based on their clinical condition.
Adults should be reviewed at least every 3 months.
More frequent review is required immediately after diagnosis
Mucolytics
Patients with cystic fibrosis who have evidence of lung disease should be offered a mucolytic.
Dornase alfais the first choice mucolytic.
If there is an inadequate response,dornase alfaand hypertonicsodium chloride, or hypertonicsodium chloridealone should be considered.
Mannitoldry powder for inhalation is recommended as an option whendornase alfais unsuitable, when lung function is rapidly declining, and if other osmotic drugs are not considered appropriate
Staphylococcus aureus
Offer an antibacterial oral or IV
Pseudomonas aeruginosa
Offer an oral antibacterial in combination with an inhaled antibacterial
Aspergillus fumigatuscomplex
Offer an antifungal drug only to suppresschroniccomplex respiratory infection in patients with declining pulmonary status
Inheritable autosomal _________ disease
reccesive
Mutations of the cystic fibrosis transmembrane conductance regulator ______ gene
CFTR
Which systems are affected?
Pulmonary and GI systems
Epidemiology of CF
equally diagnosed in males and females
What is the most common mutation
ΔF508 - a three base-pair deletion that should code for a phenylalanine (position 508)